Prestige Consumer Healthcare Inc. (PBH)
USD 79.76
(-0.59%)
USD 79.76
(-0.59%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 342.42 Million USD | -0.88% |
| 2023 | 345.46 Million USD | 4.71% |
| 2022 | 329.91 Million USD | 10.93% |
| 2021 | 297.4 Million USD | 2.15% |
| 2020 | 291.15 Million USD | 331.32% |
| 2019 | 67.5 Million USD | -68.73% |
| 2018 | 215.86 Million USD | 4.99% |
| 2017 | 205.61 Million USD | -21.01% |
| 2016 | 260.31 Million USD | 25.42% |
| 2015 | 207.55 Million USD | 10.04% |
| 2014 | 188.61 Million USD | -1.7% |
| 2013 | 191.88 Million USD | 86.62% |
| 2012 | 102.82 Million USD | 35.04% |
| 2011 | 76.14 Million USD | -3.25% |
| 2010 | 78.7 Million USD | 146.98% |
| 2009 | -167.52 Million USD | -283.26% |
| 2008 | 91.41 Million USD | -3.45% |
| 2007 | 94.68 Million USD | 12.85% |
| 2006 | 83.9 Million USD | -10.33% |
| 2005 | 93.57 Million USD | 456.86% |
| 2004 | 16.8 Million USD | -38.6% |
| 2003 | 27.36 Million USD | 83.06% |
| 2002 | 14.95 Million USD | 206.92% |
| 2001 | 4.87 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 86.83 Million USD | -1.61% |
| 2024 Q4 | 82.15 Million USD | -5.39% |
| 2024 FY | 342.42 Million USD | -0.88% |
| 2024 Q1 | 85.19 Million USD | -4.99% |
| 2024 Q2 | 88.25 Million USD | 3.59% |
| 2023 Q2 | 84.38 Million USD | -3.02% |
| 2023 FY | 345.46 Million USD | 4.71% |
| 2023 Q4 | 89.67 Million USD | 2.85% |
| 2023 Q3 | 87.18 Million USD | 3.32% |
| 2023 Q1 | 87.01 Million USD | 12.38% |
| 2022 Q3 | 82.59 Million USD | 5.14% |
| 2022 FY | 329.91 Million USD | 10.93% |
| 2022 Q1 | 91.34 Million USD | 28.76% |
| 2022 Q2 | 78.55 Million USD | -14.0% |
| 2022 Q4 | 77.42 Million USD | -6.26% |
| 2021 Q2 | 72.9 Million USD | -9.01% |
| 2021 Q3 | 73.44 Million USD | 0.74% |
| 2021 Q1 | 80.11 Million USD | 8.39% |
| 2021 FY | 297.4 Million USD | 2.15% |
| 2021 Q4 | 70.93 Million USD | -3.41% |
| 2020 Q2 | 69.34 Million USD | -2.99% |
| 2020 Q4 | 73.91 Million USD | -3.26% |
| 2020 FY | 291.15 Million USD | 331.32% |
| 2020 Q1 | 71.48 Million USD | 146.59% |
| 2020 Q3 | 76.4 Million USD | 10.17% |
| 2019 Q4 | -153.44 Million USD | -297.89% |
| 2019 Q3 | 77.54 Million USD | 9.33% |
| 2019 Q2 | 70.92 Million USD | -2.16% |
| 2019 Q1 | 72.48 Million USD | 417.61% |
| 2019 FY | 67.5 Million USD | -68.73% |
| 2018 Q4 | -22.82 Million USD | -127.33% |
| 2018 FY | 215.86 Million USD | 4.99% |
| 2018 Q1 | 79.02 Million USD | 48.96% |
| 2018 Q2 | 76.15 Million USD | -3.63% |
| 2018 Q3 | 83.5 Million USD | 9.65% |
| 2017 Q4 | 53.05 Million USD | -23.43% |
| 2017 FY | 205.61 Million USD | -21.01% |
| 2017 Q3 | 69.28 Million USD | -2.49% |
| 2017 Q2 | 71.05 Million USD | 481.78% |
| 2017 Q1 | 12.21 Million USD | -81.29% |
| 2016 Q2 | 69.89 Million USD | 11.83% |
| 2016 Q4 | 65.26 Million USD | 4.19% |
| 2016 Q3 | 62.64 Million USD | -10.38% |
| 2016 FY | 260.31 Million USD | 25.42% |
| 2016 Q1 | 62.5 Million USD | 2.06% |
| 2015 FY | 207.55 Million USD | 10.04% |
| 2015 Q3 | 56.99 Million USD | 22.52% |
| 2015 Q1 | 42.8 Million USD | -4.79% |
| 2015 Q2 | 46.51 Million USD | 8.68% |
| 2015 Q4 | 61.24 Million USD | 7.46% |
| 2014 Q2 | 53.76 Million USD | 8.74% |
| 2014 Q4 | 44.95 Million USD | 11.12% |
| 2014 Q3 | 40.45 Million USD | -24.75% |
| 2014 FY | 188.61 Million USD | -1.7% |
| 2014 Q1 | 49.44 Million USD | -1.46% |
| 2013 Q3 | 46.72 Million USD | -8.67% |
| 2013 FY | 191.88 Million USD | 86.62% |
| 2013 Q4 | 50.17 Million USD | 7.39% |
| 2013 Q2 | 51.15 Million USD | 16.71% |
| 2013 Q1 | 43.83 Million USD | 94.33% |
| 2012 Q4 | 22.55 Million USD | -4.55% |
| 2012 Q1 | 27.23 Million USD | 46.24% |
| 2012 Q2 | 29.4 Million USD | 7.96% |
| 2012 FY | 102.82 Million USD | 35.04% |
| 2012 Q3 | 23.63 Million USD | -19.63% |
| 2011 Q2 | 23.83 Million USD | 11.8% |
| 2011 Q1 | 21.32 Million USD | 39.85% |
| 2011 Q4 | 18.62 Million USD | 43.0% |
| 2011 Q3 | 13.02 Million USD | -45.36% |
| 2011 FY | 76.14 Million USD | -3.25% |
| 2010 Q2 | 21.23 Million USD | 11.39% |
| 2010 Q4 | 15.24 Million USD | -35.68% |
| 2010 FY | 78.7 Million USD | 146.98% |
| 2010 Q1 | 19.06 Million USD | 108.32% |
| 2010 Q3 | 23.7 Million USD | 11.64% |
| 2009 Q2 | 20.5 Million USD | -3.36% |
| 2009 Q3 | 19.96 Million USD | -2.63% |
| 2009 FY | -167.52 Million USD | -283.26% |
| 2009 Q4 | -229.2 Million USD | -1248.2% |
| 2009 Q1 | 21.21 Million USD | -14.44% |
| 2008 Q4 | 24.79 Million USD | 8.24% |
| 2008 Q2 | 20.61 Million USD | -10.8% |
| 2008 Q3 | 22.9 Million USD | 11.14% |
| 2008 Q1 | 23.1 Million USD | 2.09% |
| 2008 FY | 91.41 Million USD | -3.45% |
| 2007 Q1 | 23.34 Million USD | 16.35% |
| 2007 Q2 | 24.16 Million USD | 3.5% |
| 2007 Q3 | 24.53 Million USD | 1.52% |
| 2007 Q4 | 22.63 Million USD | -7.75% |
| 2007 FY | 94.68 Million USD | 12.85% |
| 2006 Q1 | 16.96 Million USD | -43.66% |
| 2006 Q4 | 20.06 Million USD | -18.92% |
| 2006 Q2 | 20.82 Million USD | 22.8% |
| 2006 Q3 | 24.75 Million USD | 18.85% |
| 2006 FY | 83.9 Million USD | -10.33% |
| 2005 Q1 | 10.65 Million USD | 0.0% |
| 2005 Q2 | 26.44 Million USD | 148.22% |
| 2005 FY | 93.57 Million USD | 456.86% |
| 2005 Q3 | 26.37 Million USD | -0.27% |
| 2005 Q4 | 30.1 Million USD | 14.15% |
| 2004 FY | 16.8 Million USD | -38.6% |
| 2003 FY | 27.36 Million USD | 83.06% |
| 2002 FY | 14.95 Million USD | 206.92% |
| 2001 FY | 4.87 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Cardinal Health, Inc. | 1.24 Billion USD | 72.451% |
| Cencora | 2.17 Billion USD | 84.258% |
| McKesson Corporation | 3.9 Billion USD | 91.24% |
| Owens & Minor, Inc. | 104.5 Million USD | -227.658% |